SCHEMBL20334652

SCHEMBL20334652

Cc1ncc(COc2cc(F)cc(Oc3ccc(-c4nn(C[C@H]5CCCN5)c5ncncc45)cc3)c2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 6/20 0.45
▸ MERTK Q12866 7/20 0.43
▸ SRC P12931 3/20 0.37
▸ EGFR P00533 2/20 0.37
▸ HCK P08631 2/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ EPHB4 P54760 1/20 0.37
▸ PRKDC P78527 1/20 0.37
▸ PI4KB Q9UBF8 1/20 0.37
▸ LCK P06239 1/20 0.34
▸ LYN P07948 1/20 0.34
▸ BLK P51451 1/20 0.34
▸ LTA4H P09960 1/20 0.33
▸ KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18268628 0.87 SRC (0.53) BTKSRCEGFRHCKPIK3CD
SCHEMBL20334651 0.82 BTK (0.52) BTKEGFRLCK
SCHEMBL16769953 0.77 BTK (0.47) BTKSRCEGFRHCKKDR
SCHEMBL16769926 0.77 BTK (0.47) BTKSRCEGFRHCKKDR
SCHEMBL15613685 0.75 SRC (0.51) BTKSRCEGFRHCKPIK3CD
SCHEMBL19353557 0.74 MERTK (0.48) BTKMERTKSRCEGFRHCK
SCHEMBL15517441 0.74 SRC (0.63) BTKSRCEGFRHCKPIK3CD
SCHEMBL18269157 0.73 BTK (0.58) BTKSRCEGFRHCKPIK3CD
SCHEMBL18268660 0.72 BTK (0.53) BTKSRCEGFRHCKPIK3CD
SCHEMBL15613529 0.72 BTK (0.61) BTKSRCEGFRHCKPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180179210-A1 Inhibitors of the TEC Kinase Enzyme Family PHARMASCIENCE INC. (CA) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179210-A1 Inhibitors of the TEC Kinase Enzyme Family TEC, BTK, LCK BTK 2/4885MERTK 111/4885SRC 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback